A randomised, controlled, comparative, open-label, multicenter study on the safety and efficacy of PEG Neutrogen and Neulastim in prevention of chemotherapy-induced neutropenia
Latest Information Update: 09 Nov 2020
At a glance
- Drugs Pegfilgrastim (Primary)
- Indications Neutropenia
- Focus Therapeutic Use
- Sponsors Virchow Group
Most Recent Events
- 04 Nov 2020 Status changed from not yet recruiting to completed.
- 22 Jun 2018 New trial record